Intervention

Bone scan

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7

Recruiting1

Common conditions14

Lead sponsors shown4

Clinical trials

7 shown

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialNCT06632977 · 2025-02-06

RECRUITING

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)NCT03493945 · 2018-05-01

COMPLETED

Combination Immunotherapy in Biochemically Recurrent Prostate CancerNCT03315871 · 2018-03-20

COMPLETED

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung CancerNCT02769962 · 2016-05-09

TERMINATED

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI StudyNCT03266744 · 2016-04-21

UNKNOWN

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving EnzalutamideNCT02815033 · 2015-07-01

COMPLETED

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving EnzalutamideNCT02814968 · 2015-02-01

COMPLETED

Common conditions

Prostate Cancer3 Prostate Cancer Metastatic2 Advanced Solid Tumor1 Castration-Resistant Prostate Carcinoma1 Lung Neoplasms1 Metastatic Breast Cancer1 Metastatic Castration-resistant Prostate Cancer1 Non-metastatic Castration-resistant Prostate Cancer1 Prostate Neoplasm1 Small Cell Lung Cancer1 Solid Tumor1 Stage IVB Prostate Cancer AJCC v81 Urothelial Cancer1 Urothelial Carcinoma1

Leading sponsors

National Cancer Institute (NCI) 3 The European Uro-Oncology Group 2 Alliance for Clinical Trials in Oncology 1 East and North Hertfordshire NHS Trust 1

Trial status mix

COMPLETED4

RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

PHASE26

PHASE12

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.